Loading...

Reminder: Do not include any PHI or PII in JIRA. If you require 508 accessibility assistance or any other support for this system, then please send an email to onc-jira-questions@healthit.gov

Implementation of 90-Day Deactivation Policy
The ONC Jira Core and Confluence support team will soon implement an account deactivation policy for all users who have not logged into the systems within the previous 90-days or more. To avoid the risk of having your account being deactivated, please immediately log into ONC Jira Core and Confluence as soon as possible. Deactivated accounts will be retained, including historic activity. Users are able to reactivate their accounts using the correct credentials used prior to deactivation.

Login Support
If you encounter a captcha prompt, login issues, or believe your account may be deactivated and require assistance, please send an email to onc-jira-questions@healthit.gov

HHS System Use Notification
This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes all devices/storage media attached to this system. This system is provided for Government-authorized use only. Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties. At any time, and for any lawful Government purpose, the government may monitor, record, and audit your system usage and/or intercept, search and seize any communication or data transiting or stored on this system. Therefore, you have no reasonable expectation of privacy. Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.

XML

Word

Printable

Type: EH/CAH eCQMs - Eligible Hospitals/Critical Access Hospitals
Resolution: Answered
Priority: Moderate
Component/s: Measure
Labels:
- Measure

Contact Name:
Janet Huff
Contact Email:
jhuff@wisehealthsystem.com
Contact Phone:
19404325781
Solution:
Thank you for your inquiry. Pradaxa does not meet VTE prophylaxis for VTE-1 and VTE-2. It is a direct thrombin inhibitor (DTI) and not an Oral Factor Xa Inhibitor.
2022 Reporting Period EH/CAH eCQMs:

CMS0108v10
Measure Title:
VTE 1 & 2
Impact:
Does Pradaxa met for VTE Prophylaxis for VTE 1 and 2?

There has been discussion if Pradaxa meets the measure for VTE eCQM. Could you please clarify if it does?

Assignee:: Joelencia Leflore

Reporter:: Janet Huff (Inactive)

Tracker Notification:: Janet Huff (Inactive)

Votes:: 0 Vote for this issue

Watchers:: 2 Start watching this issue

Created:: 08/03/22 6:20 PM

Updated:: 08/08/22 9:52 AM

Resolved:: 08/08/22 9:52 AM

Solution Posted On:: 08/08/22 9:52 AM